Financials NetraMark Holdings Inc.

Stocks

Market Closed - Toronto S.E. Other stock markets 20:30:45 16/06/2026 BST			5-day change	1st Jan Change
0.7800 ^CAD	0.00%		-7.14%	-29.09%

05-14	NetraMark Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2026	CI
05-07	NetraMark Holdings Inc. Announces Resignation of Lawrence Guy as Director, Effective May 7, 2026	CI

Fiscal Period: September	2024	2025	2026
Net sales ¹	-	0.4325	0.4009
Change	-	-	-7.3%
EBITDA	-	-	-
Change	-	-	-
EBIT ¹	-	-5.263	-6.196
Change	-	-	-17.72%
Interest Paid	-	-	-
Earnings before Tax (EBT)	-	-	-
Change	-	-	-
Net income	-3.332	-	-
Change	-	-	-
Announcement Date	22/01/25	15/01/26	-

¹CAD in Million

Estimates

Fiscal Period: September	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales ¹	-	-	-	-	0.0106	0.1212	0.1224
Change	-	-	-	-	-	1,045.94%	1%
EBITDA	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-
EBIT ¹	-	-1.361	-1.579	-	-2.213	-1.341	-1.355
Change	-	-	-16.02%	-	-	39.41%	-1%
Charge d'intérêts	-	-	-	-	-	-	-
Earnings before Tax (EBT)	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-
Net income	-1.59	-	-	-1.315	-	-	-
Change	-	-	-	-	-	-	-
Announcement Date	30/05/25	21/08/25	15/01/26	04/02/26	14/05/26	-	-

¹CAD in Million

Estimates

Fiscal Period: September	2024	2025	2026
Net Debt	-	-	-
Change	-	-	-
Announcement Date	22/01/25	15/01/26	-

Estimates

Fiscal Period: September	2021	2022	2023	2024	2025
CAPEX ¹	-	-	-	-	-
Change	-	-	-	-	-
Free Cash Flow (FCF) ¹	-0.6734	-1.463	-0.5077	-1.128	-1.867
Change	-	-117.19%	65.29%	-122.12%	-65.58%
Announcement Date	25/01/22	27/01/23	26/01/24	22/01/25	15/01/26

¹CAD in Million

Estimates

Fiscal Period: September	2020	2021	2022	2023	2024	2025	2026
Profitability
EBITDA Margin (%)	-	-	-	-	-	-	-
EBIT Margin (%)	-	-	-	-	-	-1,216.92%	-1,545.4%
EBT Margin (%)	-	-	-	-	-	-	-
Net margin (%)	-	-	-	-	-	-	-
FCF margin (%)	-	-	-	-	-	-	-
FCF / Net Income (%)	-	-	-	-	-	-	-
Profitability
ROA	-	-60.82%	-52.54%	-67.17%	-204.95%	-275.92%	-
ROE	-32.02%	-104.08%	-167.53%	-308.16%	-751.33%	-638.29%	-
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	-	-	-	-	-	-
CAPEX / EBITDA (%)	-	-	-	-	-	-	-
CAPEX / FCF (%)	-	-	-	-	-	-	-
Items per share
Cash flow per share ¹	0.0886	0.1861	0.000237	0.0271	0.00085	0.0171	-
Change	-	110.08%	-99.87%	11,320.25%	-96.86%	1,915.18%	-
Dividend per Share ¹	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-
Book Value Per Share ¹	0.0878	0.2352	0.1907	0.0165	-0.002825	0.021	-
Change	-	167.9%	-18.91%	-91.33%	-117.08%	843.22%	-
EPS ¹	-0.0599	-0.1973	-0.3317	-0.2852	-0.0494	-0.0663	-
Change	-	-229.73%	-68.06%	14%	82.68%	-34.22%	-
Nbr of stocks (in thousands)	-	33,238	42,231	65,408	70,175	87,069	-
Announcement Date	22/02/21	25/01/22	27/01/23	26/01/24	22/01/25	15/01/26	-